Zhu et al. confirmed the clinical implications of CEA, CA19-9, CA125, and positive lymph node scheme (LODDS) in predicting OS of CRC patients and conducted a novel nomogram incorporating the three tumor markers and LODDS. This evidence concerns the gene CEACAM5 and neoplasm.